⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Sermo and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Sermo
↗New York, NY, USA
Sermo is a global social platform and data insights company exclusively for verified healthcare professionals (HCPs), including physicians, nurse practitioners, physician associates, and pharmacists. The platform facilitates peer-to-peer collaboration, anonymous case discussions, and real-world medical insights.
Beyond its social networking capabilities, Sermo operates as a major market research and data intelligence provider for the pharmaceutical, biotech, and medical device industries. By leveraging its network of over 1.5 million verified HCPs, the company provides actionable insights, survey data, and brand perception analysis to help clients optimize drug development and marketing strategies.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Healthcare Market Research & Professional Networking
SIZE & FINANCIALS
Employees:501-1000
Founded:2005
Ownership:private
Status:operating
FUNDING
Total Raised:$30.2M (historical venture funding)
Investors:Abry Partners, Spark Capital, Prism Venture Works
0
CORPORATE STRUCTURE
Key Partnerships:American Medical Association (AMA), Centers for Disease Control and Prevention (CDC), Various top-20 pharmaceutical companies
COMPETITION
Position:Leader
Competitors:Doximity, Medscape, QuantiaMD
LEADERSHIP
Key Executives:
Peter Kirk - CEO
Scientific Founders:Dr. Daniel Palestrant
LINKS
Website:sermo.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Sermo. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.